key: cord-0735122-ai2mdqmx
authors: Kurakula, Mallesh; Rao, G.S.N. Koteswara
title: Type of Article: REVIEW Pharmaceutical Assessment of Polyvinylpyrrolidone (PVP): As Excipient from Conventional to Controlled Delivery Systems with a Spotlight on COVID-19 Inhibition
date: 2020-09-02
journal: J Drug Deliv Sci Technol
DOI: 10.1016/j.jddst.2020.102046
sha: 7729cfa8dd25204638052119cce3b499b83e9af4
doc_id: 735122
cord_uid: ai2mdqmx

Polyvinylpyrrolidone (PVP) is a water-soluble polymer obtained by polymerization of monomer N-vinylpyrrolidone. PVP is an inert, non-toxic, temperature-resistant, pH-stable, biocompatible, biodegradable polymer that helps to encapsulate and cater both hydrophilic and lipophilic drugs. These advantages enable PVP a versatile excipient in the formulation development of broad conventional to novel controlled delivery systems. PVP has tunable properties and can be used as a brace component for gene delivery, orthopedic implants, and tissue engineering applications. Based on different molecular weights and modified forms, PVP can lead to exceptional beneficial features with varying chemical properties. Graft copolymerization and other techniques assist PVP to conjugate with poorly soluble drugs that can inflate bioavailability and even introduces the desired swelling tract for their control or sustained release. The present review provides chemistry, mechanical, physicochemical properties, evaluation parameters, dewy preparation methods of PVP derivatives intended for designing conventional to controlled systems for drug, gene, and cosmetic delivery. The past and growing interest in PVP establishes it as a promising polymer to enhance the trait and performance of current generation pharmaceutical dosage forms. Furthermore, the scrutiny explores existing patents, marketed products, new and futuristic approaches of PVP that have been identified and scope for future development, characterization, and its use. The exploration spotlights the importance and role of PVP in the design of Povidone-iodine (PVP-I) and clinical trials to assess therapeutic efficacy against the COVID-19 in the current pandemic scenario.

Polyvinylpyrrolidone (PVP), also called as Povidone, is a synthetic polymer obtained by radical polymerization of the monomer, N-vinylpyrrolidone [1] . In 1939, German scientist Walter J. Reppe patented this process out of his acetylene chemistry research [1] . PVP is nontoxic, non-ionic, inert, temperature-resistant, pH-stable, biocompatible, and shows a complex affinity for both hydrophilic and hydrophobic drugs [2] [3] [4] . PVP is a water-soluble polymer available in different grades with varying molecular weight and viscosity [3] . In the 1940s, initially, PVP was used as a plasma volume expander [3] . In the 1950s, PVP entered into hair sprays market and replaced the shellac resin as a hair fixative agent [5] . Later PVP has gained its useful role in pharmaceutical [6, 7] , biomedical [4, 7] , cosmetics [5] , and food industry [8] . With the unique properties and chemistry of PVP, there are advancements in the synthesis of PVP to obtain varied types like homopolymers of different molecular weights, copolymers, and crosslinked PVP. [3] 2. Physicochemical properties PVP has physicochemical properties making it suitable for usage in different fields like pharmaceutical, biomedical, cosmetic, and food industry. The physicochemical properties of PVP are given in Table 1 and specific properties are shown in Figure 1 . 

PVP is classified based on its chemistry, molecular weight, or its specific characteristic as shown in Table 2 . Scanning electron microscope (SEM) photographs of the different brands of povidone, copovidone, and crospovidone are shown in Figure 2 . PVPP [3, 17, 18, 20, 21] J o u r n a l P r e -p r o o f Soluble PVP is available in different grades based on its average molecular weight, which can be determined by 3 different ways following different methods as shown in Table 3 . Table 3 : Methods for determination of the molecular weight of PVP polymer [3] Type . .

Where, z = relative viscosity of the solution of concentration, c K-value = 1000k PVP exists in different grades based on its molecular weight as shown in Table 4 . [9] Grade with Kvalue Approximate molecular weight (Daltons) PVP K-12 Figure 4 : Polymerization of N-vinylpyrrolidone [1, 3] There are 3 types of PVP as per synthetic procedure, namely, homopolymers (with different molecular weights), copolymers, and cross-linked PVP.

Free radical polymerization of N-vinylpyrrolidone either using aqueous media or organic solvent, a soluble polyvinylpyrrolidone having molecular weight range of 2500 to 1 million is produced which has high commercial value in different fields like biomedical, pharmacy, cosmetics and food industry [1, 3] . The mechanism includes free radical polymerization of Nvinylpyrrolidone in water (aqueous solution) making use of hydrogen peroxide as initiator.

By terminating the polymerization at any stage by regulating the concentration of hydrogen peroxide, the process can produce different molecular weights of soluble PVP. That's how PVP is available in different grades in the market. More the concentration of hydrogen peroxide smaller will be the molecular weight of PVP synthesized and vice versa. The mechanism of synthesis of PVP in aqueous solution is shown in Figure 5 . In addition to this simple process performed in water, it is also possible to conduct the polymerization in organic solvents like alcohol (2-propanol) , toluene, etc. to synthesize low molecular weight soluble PVP polymer meant for preparing injectables. The mechanism of synthesis of PVP in an organic solvent is shown in Figure 6 . The spray drying process is followed for the production of pharmaceutical-grade PVP of low and medium molecular weights whereas the drum drying (roller drying) process is followed for the production of high molecular weight PVP grades [9] .

J o u r n a l P r e -p r o o f [1, 3] J o u r n a l P r e -p r o o f 

With the copolymerization process, the monomer is used in the synthesis of Copovidone (E.g., vinylpyrrolidone-vinyl acetate copolymer) [1, 3] . Cationic copolymers have better adhesive properties suitable for cosmetics like hair curling agents. Anionic copolymers are soluble in oil and can be used as dispersing agents. Pictorial representations are given in 

On the other hand, if the same monomer, N-vinylpyrrolidone is undergone popcorn polymerization either by using alkali hydroxide at >100°C (produces in situ bifunctional monomer) or by direct addition of bifunctional monomer at ≤100°C in water yields an insoluble crosslinked polyvinylpyrrolidone (Crospovidone) [1, 3, [26] [27] [28] .

With versatile applications of PVP and its derivatives, more attention on their synthesis that can prepare the polymer with desired molecular weight, narrow polydispersity, and welldefined termination has been caught. In 2002 and 2004, Rimmer and Smith reported a method using 3-methyl butane-2-one as a chain transfer agent that produced PVPs with a polydispersity index (PDI) of <1.5, however it is producing low molecular weight polymers of around <10,000 [29, 30] . In 2004, Yamango et al. reported the primary results of applying organostibine-mediated living radical polymerization (LRP) followed by the first successful complete application in 2006 by Ray et al. which produced PVP of high molecular weight (Mn > 10 000) and also its block copolymers. They obtained a PDI of <1.1 for low molecular weight PVP (Mn < 15 000), and a PDI of <1.3 for even high molecular weight PVP (Mn < 1,00, 000) [31] . The researchers also prepared copolymers of PVP in a controlled manner following this LRP process [31] . In 2007, Lu et al. reported the application of atom transfer radical polymerization (ATRP) in producing PVP of molecular weight around 8900 with PDI J o u r n a l P r e -p r o o f of 1.2-1.38 [32, 33] . Advances in the procedures of controlled radical polymerization (CRP)/ LRP [34] [35] [36] [37] [38] [39] [40] [41] [42] , ATRPf [43] , and reversible addition-fragmentation transfer radical polymerization (RAFT) [44, 45] have created new avenues for better control on the synthesis of PVP and its derivatives.

PVP can be characterized and analytically determined by following several methods that are clearly described in the literature and monographs of different Pharmacopoeias [3] . Infrared spectroscopy is one important analytical method for the identification of PVP [46] . The infrared spectrum for different grades of PVP is shown in Figure 8 . [47] , vital red [48] , turbidometry, pyrolytic gas chromatography [49] . Methods especially followed to differentiate the grades of PVP include IR spectral analysis (as shown in Figure 8 ), thin-layer chromatography, paper chromatography, detection as the hydroxamic acid, and electrophoresis, nitrogen determination, gravimetric analysis, complexation capacity and solubility [3] . High-performance liquid chromatography (HPLC) and gas chromatography (GC) methods were clearly described in the literature and monographs of Pharmacopoeias for the determination of specific substances in PVP samples [3] . 

After the introduction of PVP in polymer science, extensive research has been done in developing its pharmacokinetic and toxicological profile. Different animal models and humans have been tested to study the kinetic profiling of PVP [50] . Since PVP is proposed for different fields of interest, particularly the medical, pharmaceutical, and food industry, its safety profiling became a necessity and hence detailed information has been documented in the literature. Both the individual researchers and regulatory bodies have concluded that PVP usage is safe as both a food-grade additive and also as a pharmaceutical excipient. WHO has given a listing of its acceptable daily intake of 0-50 mg/kg body weight [8] .

Upon several studies and reported detailed assessment [50] , it was found that the absorption, distribution, metabolism, and excretion (ADME) of PVP is having a relationship with the molecular weight of the polymer, dosing frequency and route of administration. Several absorption studies revealed that there are no or very limited absorption of PVP in humans, rats [51, 52] , rabbits [53] , and guinea pigs [54] . Minimal absorption has been found to result in the storage of PVP in mesenteric lymph nodes [51] . PVP is taken up by the reticuloendothelial system (RES) (mononuclear phagocyte system), following pinocytosis or phagocytosis mechanism [55] [56] [57] [58] . Ravin et al. reported that the retention of PVP in RES is proportional to its molecular weight, i.e., higher molecular weight PVP shown longer retention time [55] . Based on the studies performed in rats, dogs, and humans upon intravenous administration and verifying the samples of blood and urine, the researchers reported that there is no evidence of metabolism for the PVP in the biological system either in animals or humans [50, 57] . The primary route of excretion for low molecular weight PVP (<25,000) is through kidneys upon intravenous and intraperitoneal administration [50, 55, 57] .

Wessel et al. have reported the elimination of PVP with varying molecular weights based on then-existing literature [59] .

J o u r n a l P r e -p r o o f A good number of reports claim that PVP is biologically inert and non-toxic with good tolerance [50, 57, 59] . A huge data concerning toxicological studies in animals like rats, pigs, dogs, and rabbits revealed that orally administered PVP shows no acute or subchronic or chronic toxicity [50, 57, 60] . In some cases, an extremely low effect like diarrhea is observed at high doses. The reason is the osmotic action shown by PVP at high doses which acts as a bulk purgative [50] . There is no evidence of toxicity in terms of clinical chemistry, histopathology, and hematology except diarrhea at high doses. A mild level of deposition of orally administered PVP in mesenteric lymph nodes is also of no toxicological importance.

Intravenous and intraperitoneal routes of administration of high molecular weights of PVP shown storage in RES tissues. The reason might be due to lack of filtration of big size molecules at glomerulus. As per the reports, the LD 50 value for oral administration of PVP (average molecular weight 40,000) is greater than 100 g/kg body weight in both rats and guinea pigs. Hence, PVP is claimed as neither a sensitizer nor an irritant. Even in humans, there are no reported adverse effects with oral administration of PVP [50] . Assessment of different types of toxicity of PVP has been listed in Table 5 . Based on the toxicity studies conducted on a very extensive level it was confirmed that the PVP is a biologically inert substance. There are no or non-significant adverse effects on oral administration of PVP observed through acute, sub-chronic, and chronic toxicity studies. PVP is found to be non-toxic, non-irritant, non-sensitizer, and hence completely safe for use in animals and humans for both foods, medical and pharmaceutical applications. The accepted daily intake limit of 50 mg/kg/day proves the adequate margin of safety for PVP. PVP is found to be safe for oral and topical applications in any manner. PVP is also found to be safe for its use through ocular and dermal routes of administration based on the observations of literature reported studies with concern to molecular weight. For parenteral use, administration of PVP is warned in terms of high molecular weight, repeated dosing, and route of administration as the subcutaneous and intramuscular routes of administration shown subcutaneous granuloma [50, 61, 62] . Copovidone and crospovidone are also found to be safe with no toxicological reports and shown good tolerance [3] .

At the very early stage of the PVP introduction in the market, it was used as a blood plasma volume expander or substitute [3, 55, 63, 64] . Later PVP has found vast applications in medicine, pharmacy, cosmetics, food, and industrial production. The wide range of applications of PVP is due to its unique properties as already discussed and also, its ability to interact with low molecular weight compounds. Various applications of PVP are listed in Figure 9 . The diversity in applications of PVP is majorly due to the tailored properties based on its molecular weight and polymerization method. For example, the rate of dissolution is inversely proportional to the molecular weight whereas the viscosity, complexing nature, and adhesive power are directly proportional to the molecular weight of PVP. Even the biological elimination of PVP upon parenteral administration is also inversely proportional to its molecular weight. Hence, a specific molecular weight PVP that is suitable for the desired application has to be selected. Researchers have used PVP ranging from conventional dosage forms to controlled release systems. In the present review, a detailed note on the applications of PVP in both areas is presented.

J o u r n a l P r e -p r o o f 

Several conventional dosage forms where PVP has been used is shown in Figure 10 . PVP is used as a binder in all the wet granulation modified methods, fluidized bed granulation [66, 67] , and extrusion spheronization [68, 69] . PVP can also be used in combination with different grades or with other binders because of its good compatibility and to obtain any specific desired properties like plasticity. Examples of formulations include rifampicin, pyrazinamide, ranitidine effervescent, ascorbic acid effervescent tablets, etc. PVP polymers also gained a place in dry granulation [70] and direct compression [71] techniques.

Direct compression is the simplest tableting process among all available methods. However, all drugs are not having a compressibility nature suitable for this method. In such a case, the concept of using auxiliaries available readymade in the market or by developing drug-binder mixtures suitable for direct compression is in use. PVP is also used as a binder in pre granulation forms of active substances meant for direct compression otherwise which are prone to hydrolysis in the wet granulation method. PVP is also used to develop direct compression auxiliaries (e.g., lactose granules for direct compression) and granulation of active ingredients (pre-granulated ascorbic acid granules with povidone) for direct compression [3] .

J o u r n a l P r e -p r o o f

Because of its hydrophilic and film-forming nature, PVP avoids micro-cracks during the sugar-coating process and also aids for better adhesion of the applied coating layer over the hydrophobic core. Color solutions or suspensions also show homogenous distribution with the presence of PVP in a coating mixture representing its dispersing effect. PVP also maintains the stability of sugar suspension because of its crystal growth-inhibiting property.

With the properties of film-forming, adhesiveness, an affinity for the hydrophobic surface, and dispersive, PVP is also used in film coating of tablets [72] . However, PVP is not used alone as a sole film former in coating mixtures because of its hygroscopicity. PVP is also used as an additive in the enteric coating of tablets along with enteric coating polymers [73] .

PVP is used as a binder to prepare granules and pellets as final dosage form (e.g., effervescent, chewable, dry syrup, or instant for dispersion), or else they can be further used for tableting or filling into hard gelatin capsules or coating. Ascorbic acid granules prepared by dry granulation through roller compaction using PVP K30 as a dry binder is the typical example [74] . PVP is useful for preparing highly concentrating solutions (by enhancing the solubility of active ingredients with its hydrophilic nature) that can be filled in soft gelatin capsules [75] .

PVP is used as a solubilizer to enhance the solubility, dissolution rate, and hence bioavailability of poorly soluble drugs in different formulations. The role of PVP in increasing the physical stability of amorphous drugs by preventing the crystallization in the solid-state and maintaining the drug supersaturation after dissolution has been proved in many studies [76, 77] . PVP forms water-soluble complexes, because of its hydrophilic nature, with many drugs of low molecular weight, and also avoids crystallization of dissolved drugs.

For example, the dissolution rate and hence the bioavailability of indomethacin, have been increased with the use of PVP [78] . Major factors that influence the magnitude of dissolution rate or bioavailability enhancement include the method of preparation (e.g., melting, coprecipitation, extrusion, solvent evaporation, physical mixing), the ratio of drug to PVP and molecular weight of PVP. Several drugs like phenytoin [79] , sulfathiazole [80] , hydrocortisone [80] , disulfiram [81] have reported data with enhanced dissolution rate and/or bioavailability. Verma et al. prepared inclusion complexes of famotidine with cyclodextrin and PVP following spray drying technique to increase drug solubility [82] . They employed quality by design (QbD) approach using Plackett-Burman design as a systematic process. The as the model drug [83] . PVP blends with PEG 400 and PEG 600 were found to be completely miscible. All the prepared formulations showed long-term physical stability up to 18 months at ambient temperature. The studied dissolution parameters showed good prediction ability as per artificial neural networks. Frizon et al. prepared and evaluated solid dispersions of loratadine to enhance its dissolution rate by using PVP K30 as a hydrophilic carrier [84] . The investigation revealed that PVP based solid dispersions have increased the solubility of poorly soluble drugs prepared by following rotary evaporation and spray drying methods.

PVP was used as a polymer to form amorphous solid dispersions with indomethacin within the tablet in situ by using microwave irradiation [85] . Dissolution rate enhancement of poorly soluble drugs like curcumin, silymarin, carbamazepine, nimodipine, β-lapachone, tadalafil, gliclazide, carvedilol were also reported using PVP. Supercritical antisolvent coprecipitation technique was followed to improve the solubility of poorly water soluble drugs like nimesulide and cefuroxime with the use of a hydrophilic polymer, PVP. [86, 87] 

PVP has been used as an additive in the liquisolid technique for the enhancement of the dissolution rate of poorly soluble drugs. Molaei et al. has conducted a study to improve the dissolution rate of poorly water-soluble drug, ketoconazole by preparing liquid-solid compacts. They used microcrystalline cellulose as a carrier, colloidal silica as a coating material, PEG400 as a nonvolatile solvent and PVP as additive [77] . In another work, the presence of PVP as an additive in liquid-solid compacts has shown an increased dissolution rate of carbamazepine than the compacts prepared by direct compression. [76] . It is claimed that PVP inhibits crystal growth by inhibiting the drug precipitation from supersaturated liquid medication and also it helps in providing increased exposed drug surface area against the dissolution medium due to adsorption on the carrier.

Elagamy et al. developed and evaluated rapidly dissolving buccal films using HPMC and PVP K30 for naftopidil [88] . Loading of the films was done with either pure form of drug or co-grinded form (with citric and/or tartaric acid) or as a self-micro emulsifying system (mixed with plurol oleique, labrasol, and tween 80). Naftopidil in the HPMC-PVP film J o u r n a l P r e -p r o o f developed a new crystalline structure. The crystalline nature got abolished in the presence of organic acids or self-micro emulsifying systems. In-vitro and in-vivo evaluation using the rabbit model revealed that there is a significant enhancement of the dissolution rate as well as bioavailability of the selected model drug administered as a buccal film.

PVP polymer has wide applications in oral liquids (e.g., oral drops, solutions, suspensions, dispersions, emulsions) as solubility enhancers for several poorly soluble drugs like diclofenac [89] . With medium and high molecular weight PVP (acting as a thickening agent), desired viscosity of the liquid dosage form can be obtained which aids for constant drip rate, better appearance, dispersion, and physical stability. PVP is also reported for the taste masking effect [90, 91] in products containing acetaminophen, trimethoprim, and sulfamethoxazole. PVP is used as a crystal growth inhibitor to avoid crystallization of product ingredients e.g., in syrups where cap locking is the problem [92] .

PVP has applications like suspending, dispersing, stabilizing and viscosity-enhancing (thickening) agent in numerous oral liquids (dry syrups/ suspensions/ emulsions/ dispersions/ instant granules for reconstitution) [93, 94] . PVP acts as a protective colloid and can effectively stabilize suspensions, emulsions, and dispersions by adsorbing as a thin molecular layer over the surface of the individual colloidal particles to avoid contact, aggregation or coalescence. This might also be attributed to hydrophilic nature rendered to the individual solid particles and letting them stay away from each other due to steric hindrance. As the viscosity is also enhanced by PVP, the sedimentation rate is reduced as per Stoke's law.

Hence, better dispersibility is achieved and the sedimentation volume can be increased. The stability of suspensions can also be enhanced due to the addition of PVP as it reduces the zeta potential of substances like iron oxide pigments [95] . PVP is used as a binder for the preparation of instant granules or dry syrups meant for reconstitution as suspension. Medium and high molecular weight PVP grades are used in oral suspensions whereas low molecular endotoxin-free grades are used in suspensions meant for parenteral administration [96, 97] .

PVP is used to increase the contact time of eye products by enhancing the viscosity (thickness) of drug solutions and also acts as an effective lubricant for dry eyes [98, 99] . In ophthalmics also, PVP can be used as a crystal growth inhibitor. PVP can also act as a J o u r n a l P r e -p r o o f solubilizer to obtain clear solutions meant for ophthalmic use and also aids for improved effect and bioavailability of active ingredients [33, 100, 101] . PVP also aids in reduced irritation caused by formulations [102] . Oxymetazoline irritant effect is reduced by using soluble PVP in ophthalmics [3] . The cleaning solutions for contact lenses are also prepared by PVP [103, 104] . PVP is also used as a suspending, thickening or stabilizing agent for ophthalmic suspensions. Examples of drugs used in ophthalmics in combination with PVP include chloramphenicol, pilocarpine, timolol, prednisolone, etc. In the case of ophthalmics, low molecular weight grades are used for eye drops and suspensions whereas high molecular weight grades are preferred for contact lens solutions [105] .

In parenteral, PVP polymers are used for solubilization or dispersion of drugs in injectable products for human or veterinary use. A low molecular weight endotoxin-free (pyrogen-free)

PVP is easily eliminated upon parenteral administration without accumulation and hence PVP K12 or K17 are preferred than other grades with high molecular weight [50] . Injections of antibiotics, rifampicin, oxytetracycline are examples in which PVP is used as a solubilizer.

PVP can also be successfully used in the lyophilization process of preparing injections for better solubility and stability [96, 106, 107] . PVP has been used to boost the viscosity of intracytoplasmic sperm injection [33, 108] .

In transdermal products like ointments, creams, and gels, PVP is used to develop hydrogels (that act as diffusion matrix) and as a crystal growth inhibitor in certain drug-adhesive matrix systems. Because of the excellent adhesive property shown by PVP in addition to its physiological safety and inertness, it is used as an adhesive in several mucoadhesive drug delivery systems [109, 110] and transdermal systems [111] because of its properties like adhesiveness, crystal inhibition, solubilization, etc. Transdermal products include gels, patches, buccal tablets, meant for adhesion to the skin or mucous membrane [112] [113] [114] .

Examples of drugs used along with PVP in transdermal products include captopril, chlorhexidine, bromhexine, isosorbide dinitrate, etc. PVP has found its valuable presence in the adhesive systems. Even it is also used in diagnostic applications like contact gel for electroencephalogram (EEG), electrocardiogram (ECG), and colostomy bags [115] . Rac et al. found that the addition of PVP to polyacrylic acid cryogels for transdermal drug delivery has shown decreased swelling, increased adhesivity, and compression moduli [113] . PVP is used as an adhesive or in adhesive formulations to fix medical electrode leads or ultrasound leads J o u r n a l P r e -p r o o f to the skin. It is also used for coating as a lubricating agent on medical devices like catheters.

PVP is used as a pore-forming agent in membrane technology like haemodialysis membranes.

PVP based nasal sprays and in-situ gel for nasal drug delivery are reported. A detailed report on the clinical study of liposomal povidone-iodine nasal spray has been published by those researchers [116] . In the latest pandemic coronavirus disease condition due to COVID-19, PVP-iodine nasal spray is proposed for avoiding or minimizing the cross-infection risk to the front line doctors or workers [116, 117] . PVP can increase the mucociliary clearance timings of nasal applications [118] .

Suppositories for better drug release or sustained have been developed using PVP as an excipient along with other formulation ingredients. Liquid suppositories are also reported by PVP applications [112] . Saleem et al. reported the use of PVP along with agar for developing sustained release rectal suppositories of tramadol hydrochloride [119] .

PVP has also been popularly used in designing controlled release systems. Herewith presented some of the prominent areas of research in controlled drug delivery as shown in osmogen, and ethyl cellulose as a coating material [123] . Studies revealed that the drug release was directly proportional to the concentration of pore former, PVP in the coating membrane, and inversely proportional to the membrane weight.

Chun et al. developed novel mucoadhesive floating granules of acetaminophen using the Carbopol-PVP interpolymer complex to achieve controlled drug release. Sodium bicarbonate was used as a gas-generating agent [109] . At a complex ratio of 1:1, the system has shown 

Several novel carrier systems have been developed using PVP and its derivatives as shown in Figure 11 . Some of the promising works are discussed here. 

Dasankoppa et al. followed gamma radiation-induced polymerization for the preparation of nanogels (pH-sensitive hydrogel nanoparticles) with acrylic acid in an aqueous solution of PVP as a template polymer through crosslinking complexation mechanism and hydrogen bonding interaction [123] . PVP molecular weight was found to be one of the important parameters that influence the particle size and swelling ability of the nanogels. A novel method has been reported for the preparation of complex nanogels comprising of PVP and poly (2-acrylamido-2-methylpropane sulfonic acid) (PAMPS) in PVP aqueous solution.

These nanogels exhibited a pH-induced phase transition with the protonation effect on PAMPS chains. These nanogels are found to apply to the development of pH-controlled drug delivery systems [131] . Bueno et al. prepared PVP superabsorbent nanogels following Fenton reaction using PVP and the aqueous pool of hexadecyltrimethylammonium bromide reverse micelles. With tenfold swelling ratio, these are characterized as efficient superabsorbent nanogels and the swelling was proposed to be dependent on bound Fe3+ varied with pH and ionic strength [132] . A detailed review has been published by Kadlubowski on the radiationinduced synthesis of PVP nanogels [133] .

Yu et al. developed a core/sheath nanofibers of ketoprofen using PVP as the sheath polymer and ethyl cellulose as the core matrix following the coaxial electrospun method [134] . The system has shown a biphasic drug release profile with initial immediate release followed by 

Mennini et al. used PVP for the preparation of a ternary complexation system of the drug, celecoxib with hydroxypropyl-β-cyclodextrin and PVP K30 to enhance the solubility of the drug and for better vectorization during the development of chitosan-calcium alginate microspheres [137] . Results revealed that the ternary complexation system has shown better drug dissolution rate than the binary system of drug-cyclodextrin in turn which is better than that of pure drug alone. Kim and Park prepared and evaluated porous microcapsules of poly(ε-caprolactone) (PCL)-Eudragit RS100 using tulobuterol as model drug following solvent evaporation method in which drug and PVP were dissolved in dichloromethane along with polyvinyl alcohol to obtain pre-emulsion [138] . Several researchers have developed J o u r n a l P r e -p r o o f microspheres/microparticles for the enhancement of the dissolution rate by following different techniques [139] [140] [141] .

Marizza et al. developed a technique for the effective loading of poorly soluble drugs in micro containers [142] . They combined the concepts of inkjet printing and supercritical fluid impregnation. Ketoprofen was used as a model drug and PVP as a polymer. PVP solutions were dispensed into the microcontainers with a quasi-no-waste performance by inkjet printing whereas drug is impregnated in the polymer matrix following supercritical fluid technology using supercritical fluid carbon dioxide as loading medium. The dissolution rate with the reproducibility of such drug-loaded polymer filled micro containers was found to be better than that from solid dispersions prepared with the same ingredients. The blend of these loading techniques has shown feasibility for the rapid fabrication of microdevices suitable as oral drug delivery systems with a safe and solvent-free solution. 

PVP is highly used to develop hydrogels due to its swelling properties in an aqueous containing chitosan and clay as nanoparticles using glucantime as a model drug [148] .

Interactions of chitosan and clay with PVP were studied and reported their influence. The release of the drug was found to be influenced by the swelling rate of the PVP-clay system and the PVP-chitosan-clay system. Ahmad et al. prepared and characterized crosslinked PVP hydrogels with 3 different compositions (drug: polymer ratio of 1:1, 1:2, 1:3) using theophylline as a model drug [149] . They concluded that the increased concentration of PVP decreased the release rate of the drug from hydrogel-based compacted matrix tablets. Jin et al.

developed novel pH-and electrical-sensitive hydrogels using PVP-polyacrylic acid (PAA) copolymers [150] . Such pH-and electric-sensitive hydrogels are suitable for use in sensors, actuators, switches, and drug delivery systems. The results declared that that PVP coated GO has shown better immunological compatibility with less immunogenicity and significantly delayed the apoptotic process of T-lymphocytes than the uncoated GO. A brief list of major pharmaceutical applications of PVP is given in Table 6 . 

Plastics are highly used in polymers for medical applications [154, 155] . However, they suffer from the hydrophobic nature for their use in direct contact with blood, plasma, tissues, etc.

Hence, plastics are hydrophilized with additives like PVP because of its amphiphilic nature.

PVP due to its complex-forming nature reduces the irritancy levels or toxicity with numerous drugs like oxytetracycline on their parenteral administration [156] . PVP also reduces the irritation or toxicity of products (containing drugs like oxymetazoline, iodine) applied topically to skin or eye. PVP also reduces irritant or toxicity effects of certain other substances like nicotine, cyanide, formaldehyde, formamide, toxins, etc. because of its complexation property [3] .

PVP acts as a cryoprotectant during the lyophilization process involving freeze-drying. It inhibits the crystallization of water and drugs. The cryoprotection property of PVP plays a major role in the biotechnology field than in drug manufacturing [3] . Thirumala et al. studied the application of PVP as a cryoprotectant for preserving the human adipose tissue-derived adult stem cells using liquid nitrogen. They have replaced dimethylsulfoxide with high molecular weight PVP as cryoprotectant [157] .

By forming complexation with the enzyme deactivating moieties like phenols and tannins, PVP can play a role as an enzyme stabilizer [3] . This principle is useful in the stabilization of diagnostic reagents (rapid test kits) and microbiological processes. Zhang et al. has used PVP functionalized silicone particles for lipase immobilization to develop a low-cost process. The rational design is based on the interfacial activation and solution polymerization. The activity assay revealed that lipase immobilized with PVP functionalized silicone particles has exhibited higher catalysis activity and also better thermostability and reusability compared with hydrophilic pristine or hydrophobic polystyrene corded silicone particles [158] . Other examples include asparaginase, catalase, galactosidase, etc.

PVP is useful for the stabilization of drugs. Regulska [161] . PVP also stabilizes several active substances in different dosage forms e.g., nitroglycerine, isosorbide dinitrate, ascorbic acid, interferon, iodine, theophylline, etc [3] .

PVP has more potential for forming complexes with drugs or other polymers which shows an influence on the solubility, dissolution, and stability of drugs or products [154, 162, 163] . The unique nature of PVP is the coexistence of hydrophilic and hydrophobic segments which allows complexation with a variety of compounds like low molecular weight substances and several polymers [164, 165] . The binding mechanisms may include either of the interactions like hydrogen bonding, polar or hydrophobic attractive forces [166] . The increased potential of PVP for complexation is attributed to the ability of a polymer to form tertiary complexes.

PVP forms complexes with tannins and polymethacrylic acids due to hydrogen bonding. An example of hydrophobic interactions is the complexation of PVP with phenols (e.g., resorcinol and pyrogallol) which also associates with the exothermic interaction between an 

PVP has been used as soluble polymer support to bind metal complexes, thus formed PVP bound metal acts as a catalyst (heterogenized homogeneous catalyst) [171] . The carbonyl oxygen moiety and the amide nitrogen moiety allow PVP to act as an efficient ligand for binding the monodentate and bidentate metal ions. The ligand-metal complex thus obtained is stable and acts as a soluble but recoverable catalyst in reactions.

Penjweini et al. have studied the application of a photosensitizer, PVP-Hypericin in conventional photodynamic diagnosis and therapy with fluorescence imaging studies using living human lung epithelial cancer cells (A549) [172] .

PVP has also found application in DNA purification due to its polyphenol absorbing nature [173] . PVP is a component of Denhardt's buffer solution which is used for blocking the nonspecific binding sites during microarray analysis, northern & southern blot analysis, and nucleic acid gel electrophoresis [174] . PVP has found application as an adhesive stick and as J o u r n a l P r e -p r o o f a remoistenable adhesive. High molecular weight PVP is also useful as a protective colloid and particle size regulator for suspension polymerization of vinyl chloride, styrene, and vinyl acetate. PVP is also used as a dye affinity stripping and leveling agent in textile dyeing [1] .

Copovidone (vinylpyrrolidone-vinyl acetate copolymer), a more plastic and less hygroscopic copolymer, is also having a high binding capacity and hence used as a dry binder in direct compression technique. Copovidone is also used as a solubilizing agent, granulating agent, and colloidal silicon dioxide) [177] . Thorough in vitro characterization was done and developed a mechanistic realistic mathematical theory to predict the effects of tablet dimensions on drug release.

Cross-linked PVP also called crospovidone, is insoluble in water and highly compactable.

Crospovidone is used as a super disintegrant in tablets and suppositories due to its high J o u r n a l P r e -p r o o f swelling properties, unlike soluble PVP [178, 179] . Ludipress is a novel excipient which contains lactose (as filler/carrier), Kollidon K30 (binder, povidone) and Kollidon CL (super disintegrant, crospovidone) and hence, the manufacturer can simply mix the active ingredient with this Ludipress and lubricant, followed by direct compression which saves a lot of time and processing. Kasperek et al.et al. prepared and evaluated the modified release tablets of papaverine HCl using Kollidon 30 (PVP K30) as a binder, Kollidon SR as a sustained-release polymer and Kollidon CL (crospovidone) as disintegrant following direct compression method [71] . The results showed good control over the drug release with the optimized formulation.

PVP has a wide number of applications in cosmetics. It acts as a binder, film former, hair fixative, dispersing agent, surfactant, viscosity enhancer, and stabilizer in different cosmetic products [180] . Different cosmetic products that are prepared with PVP as an ingredient include shampoos, hair sprays, hair setting lotions, eye shadows, eyeliners, mascara, lipsticks, nail polishes, shaving creams, moisturizers, etc and its use in cosmetics is reported to be as safe [181] 

Several marketed pharmaceutical products are prepared with PVP in their formulation for some of the other purposes as discussed in previous sections. A list of commercially available products is given in Table 7 . 

PVP has been recognized by many countries as an essentially nontoxic excipient (nonmedicinal ingredient) and food-grade additive [9] . PVP is approved by the FDA [182] . PVP 

There are several patents based on the application of PVP in pharmaceutical products. A list of patent prospection in this decade are presented in Table 8 . J o u r n a l P r e -p r o o f

Even though PVP has been identified as a popular pharmaceutical excipient, food additive, and cosmetic ingredient, it has its disadvantages as limitations for its usage at certain levels.

PVP or its derivatives have been claimed for certain allergic reactions [33, [183] [184] [185] , storage disease, subcutaneous granulomas, pulmonary vascularization, and reticuloendothelial system (RES) deposition [50, 186] . Some of them are overruled and some are given cautions to overcome them. Avoiding repeated dosing, high molecular weight, a large amount of PVP at the same site of administration can be a remedy to avoid certain such problems. An important disadvantage of PVP is its high hygroscopic nature which made it tough to store and handle. The influence of hygroscopicity on the tackiness of PVP film can be avoided by adding acetylated monoglycerides to the coating mixture [187] . PVP has a major limitation for parenteral administration due to its non-biodegradability. Only low molecular weight pyrogen-free polymers of PVP are suitable for parenteral administration as they are only able to get excreted through kidney [50] .

A novel coronavirus, SARS-CoV-2, the causative agent was responsible for Coronavirus Further, the potential use of PVP-I and prophylaxis on nasopharyngeal and oropharyngeal mucosa of COVID-19 patients, healthcare professional, and community as an ancillary measure to diminish the pandemic is also described in J o u r n a l P r e -p r o o f PVP-I 7 % gargle/mouthwash showed rapid bactericidal activity and virucidal efficacy in vitro at a concentration of 0.23 % PVP-I and may provide a protective oropharyngeal hygiene measure for individuals at high risk of exposure to oral and respiratory pathogens.

Preoperative povidoneiodine (PVP-I) protocol for lacrimal surgies A drop of 1 % PVP-I Administrated in a conjunctival cul-de-sac with contact time for 3 minutes against COVID-19.

[192]

Povidoneiodine (PVP-I) 0.23 % to 7 % solution Topical preparations exhibited virucidal activity [193] 7.

Povidoneiodine (PVP-I) 0.5%, 1%, and 1.5% Oral antiseptics showed complete inactivation of SARS-CoV-2 within 15 seconds of contact. [194] J o u r n a l P r e -p r o o f 47 

Povidoneiodine (PVP-I) 1% eye drop Locally (eye drop) effective in case of accidental ocular exposure or case of 2019-n CoVassociated conjunctivitis. [195] 9.

Povidoneiodine Insitu Gel forming formulations.

PVP-I gel-forming nasal spray (IVIEW-1503) and PVP-I gel-forming ophthalmic eye drop (IVIEW-1201)

Formulations can reduce or prevent the transmission of the virus through the nasal cavity and the eye. [196] 10. Povidone-Iodine prosthodontic practice 0.5 % oral wash Oral rinse can decrease the risk of transmission associated with viral shedding from asymptomatic individuals. [197] 11. Povidoneiodine (PVP-I) topical and oral antiseptic solution (PVP-I 10%), skin cleanser (PVP-I 7.5%), gargle and mouth wash (PVP-I 1%) and throat spray (PVP-I 0.45%) achieved ≥ 99.99% virucidal activity against SARS-CoV-2, corresponding to ≥ 4 log10 reduction of virus titre, within 30 s of contact [198] 12. Povidoneiodine (PVP-I) vs. hydrogen peroxide PVP-I oral antiseptic rinse at all 3 concentrations of 0.5%, 1.25%, and 1.5% and hydrogen peroxide solutions at concentrations of 1.5% and 3.0%.

After the 15-second and 30second contact times, PVP-I oral antiseptic rinse at all 3 concentrations of 0.5%, 1.25%, and 1.5% completely inactivated SARS-CoV-2. The H2 O2 solutions at concentrations of 1.5% and 3.0% showed minimal viricidal activity after 15 seconds and 30 seconds of contact time. [199] J o u r n a l P r e -p r o o f 48 Apart from exploring the PVP-I as a preventive aid against COVID-19, it is even important to notice the minimal side effects or rare adverse effects by prolonged use [200] . PVP-I is reported for allergic reactions and should not be used in patients suffering from thyroid diseases [201] . Studies even indicated that prolonged use of topical 10 % PVP-I solution (weeks-months) may increase the risk of iodine toxicity [202] . Kim J.H. et al. reported a ciliotoxic effect on ciliated human respiratory cells on longer-term use of betadine that indicates the cautionary use [203] . Previous studies even conducted investigations in understanding the allergy, contact sensitivity, and skin reactions associated with the use of PVP-I [203] . As per current studies, there is a scope for a lot more research in the area of PVP I against COVID-19. The researchers have challenges to combat the limitations of PVP I and have the necessity to focus on developing delivery strategies minimizing the side effects.

In the current scrutiny, synthesis, grades, properties, and applications of PVP as a pharmaceutical excipient are discussed. PVP is FDA approved and extensively used in the formulation of conventional to controlled drug delivery systems by pharmaceutical industries [50] . PVP use as a synthetic polymer excipient in developing a wide range of novel drug delivery systems has been widely researched, as backed by the available literature. Further studies are required to assess and safely regulate the use of PVP in designing especially programmable or modified delivery systems intended for oral delivery [3] . For instance, PVP use can be limited and require special handling for being hygroscopic containing 18% moisture at 50% RH [33] . Cross-povidone is also reported for non-biodegradable behaviour reporting allergic manifestations and even may cause pulmonary vascular injury [186] . PVP not just has wide applications in pharmaceutical but also in food and cosmetic industries. As a solubilizer, stabilizer in suspensions, emulsions, creams of photoresist capacity, ophthalmic formulations, and many more [154] . The uncountable properties of PVP create the scope and advance more applications in other sectors as well. PVP is also being explored for its use in dental products, dietary supplements, herbal products, and functional foods. PVP is costeffective if used in available modified grades instead of synthesis from start. New futuristic grades are being identified and patent-protected opening spell to the generic industry. The novel grades need to be studied in detail with supporting toxicological profiling before use [50] . Overall PVP is a multifaced, long credited, and well-ensconced excipient in the pharmaceutical industry and enrooting its way in broad novel drug delivery systems J o u r n a l P r e -p r o o f providing new paradigm in chronic therapies [154] . Molecular conjugation for production of co-processed PVP based excipients with exceptional functionality is yet another boulevard.

Based on the current literature survey, PVP is considered a widely used excipient for pharmaceutical, food, and cosmetic industry. PVP as a polymer has a profound effect on solving many drug-related issues that could not be construed by modifying the chemistry or formulation approaches. The biodegradable character, strong stability, mild physiochemical properties, ability to solubilize, being non-toxic, and capacity to deliver both hydrophilic and Tables   Table 1 Physicochemical properties of PVP Table 2 Classification of PVP Table 3 Methods for determination of the molecular weight of PVP polymer Table 4 Approximate molecular weights of different grades of PVP Table 5 Toxicity status of PVP Table 6 Major pharmaceutical applications of PVP Table 7 Some of the commercially available products formulated with PVP Table 8 Patents related to application of PVP in Pharmaceuticals Table 9 Various studies and clinical trials reported on use of Povidone-iodine (PVP-I) against COVID-19 Table 10 Current ongoing clinical trials demonstrating the benefits of Povidone-Iodine (PVP-I) as intranasal and gargling use against COVID-19 patients 

Validation, Methodology, Resources, Writing-review & editing

Polymers of n-vinylpyrrolidone: Synthesis, characterization and uses

Polyvinylpyrrolidone (PVP) in nanoparticle synthesis

Polyvinylpyrrolidone -Excipients for Pharmaceuticals: Povidone, Crospovidone and Copovidone, illustrate

Poly(N-vinylpyrrolidone)-Modified surfaces for biomedical applications

Herbal Cosmetics Handbook

Preparation and Evaluation of Acetaminophen Tablets

Biomaterials of PVA and PVP in medical and pharmaceutical applications: Perspectives and challenges

Handbook of pharmaceutical excipients

The Merck Index -An Encyclopedia of Chemicals, Drugs, and Biologicals

Technical literature: Soluble Kollidon Grades, Soluble Polyvinylpyrrolidone for the Pharmaceutical Industry

Bimetallic catalysts: Requirements for stabilizing PVP removal depend on the surface composition

A general method for the controlled embedding of nanoparticles in silica colloids

Self-organized monolayer of nanosized ceria colloids stabilized by poly(vinylpyrrolidone)

Food Chemicals Codex

Effect of Water Vapor Sorption on Local Structure of Poly(vinylpyrrolidone)

Technical literature: Vivapharm PVP/VA

Technical literature: Vivapharm PVPP

Agrimer TM polyvinylpyyrolidone (PVP)

Technical literature: Vivapharm PVP

Evaluation of the functional equivalence of crospovidone NF J o u r n a l P r e -p r o o f from different sources. I. Physical characterization

Systematics of celluloses based on their viscosity in solution

XI : Polyacetale, Epoxidharze, fluor-haltige Polymerisate, Silicone usw

Ullmanns Encyclopädie der technischen Chemie, 4. Auflage, Verlag Chemie

Studies on the free radical polymerization of N-vinylpyrrolidinone in 3-methylbutan-2-one

Novel amphiphilic diblock copolymer of low molecular weight poly(Nvinylpyrrolidone)-block-poly(D,L-lactide): Synthesis, characterization, and micellization

Highly versatile organostibine mediators for living radical polymerization

Controllable synthesis of poly(Nvinylpyrrolidone) and its block copolymers by atom transfer radical polymerization

Poly(vinylpyrrolidone)

Living Free-Radical Polymerization by Reversible Addition-Fragmentation Chain Transfer: The RAFT Process

Step-growth polymers as macroinitators for "living" radical polymerization: Synthesis of ABA block copolymers

Ultrafast synthesis of ultrahigh molar mass polymers by metal-catalyzed living radical polymerization of acrylates, methacrylates, and vinyl chloride mediated by SET at 25 °C

Single-electron transfer and single-electron transfer degenerative chain transfer living radical polymerization

Highly controlled synthesis of poly(Nvinylpyrrolidone) and its block copolymers by organostibine-mediated living radical polymerization

Thermo-responsive diblock copolymers of poly(N-isopropylacrylamide) and poly(Nvinyl-2-pyrroridone) synthesized via organotellurium-mediated controlled radical polymerization (TERP)

Highly controlled living radical polymerization through dual activation of organobismuthines

Synthesis and applications of polystyreneblock-poly(N-vinyl-2-pyrrolidone) copolymers

Functional polymers by atom transfer radical polymerization

Universal (Switchable) RAFT agents

RAFT polymerization of N-vinylpyrrolidone mediated by cyanoprop-2-yl-1-dithionaphthalate in the presence of a fluoroalcohol: The possibility of altering monomer properties by hydrogen bonding?

Qualitative determination of polyvinylpyrrolidone type by near-infrared spectrometry

Identification and determination of polyvinylpyrrolidone(PVP) as well as determination of active substances in PVP-containing drug preparations

Universal Chromatographic-Colorimetric Method for the Determination of Trace Amounts of Polyvinylpyrrolidone and Its Copolymers in Foods, Beverages, Laundry Products, and Cosmetics

Trace determination of high molecular weight polyvinylpyrrolidone by pyrolysis-gas chromatography

PVP : a critical review of the kinetics and toxicology of polyvinylprrolidone (povidone)

A review of the physiological properties of PVP

Unpublished report from the Industrial Biological Research and Testing Laboratories

Intestinal absorption of polyvinylpyrrolidone

Tolerance and side-effects of various Kollidons administered by mouth and their behavior in the gastrointestinal tract (translation from German), Doctors' Thesis

Polyvinyl pyrrolidone as a plasma expander

Effects of temperature, metabolic inhibitors and some other factors on fluid-phase and adsorptive pinocytosis by rat peritoneal macrophages

Polyvinylpyrrolidone (PVP), its diagnostic, therapeutic and technical application and consequences thereof

WHO Food Additives Series 15), IPCS Inchem

Storage of Polyvinylpyrrolidone (PVP) in Tissues Following Long-Term Treatment with a PVP-Containing Vasopressin Preparation

Subcutaneous pseudosarcomatous polyvinylpyrrolidone granuloma

Blood plasma expander-PVP

Evaluation of Polyvinyl Pyrrolidone as a Plasma Expander

Formulation development of chewable albendazole tablets with improved dissolution rate

A comparison of granules produced by high-shear and fluidizedbed granulation methods

Effect of polyvinylpyrrolidone solutions containing dissolved drug on characteristics of lactose fluidized bed granules

Effect of binder level and granulating liquid on phenylbutazone pellets prepared by extrusion-spheronization

Gellan gum and polyvinylpyrrolidone (PVP) as binding agents in extrusion/spheronization pellet formulations

The Effect of the Physical States of Binders on High-Shear Wet Granulation and Granule Properties: A Mechanistic Approach Toward Understanding High-Shear Wet Granulation Process

Granulation and Granule Properties

The application of povidone in the preparation of modified release tablets

Polyvinylpyrrolidone (PVP); its properties and new use in tablet coating

Preparation of 5-aminosalicylic acid enteric time-controlled released tablets and study on their dissolution

Preparation of ascorbic acid granules

Preparation and Evaluation of Valsartan Liquid Filling Formulations for Soft Gels

Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine)

Enhancement of ketoconazole dissolution rate by the liquisolid technique

Factors Affecting the Dissolution of Indomethacin Solid Dispersions

Dissolution rates of partially water-soluble drugs from solid dispersion systems

Drug membrane transport enhancement using high energy drug polyvinylpyrrolidone (PVP) co-precipitates

Preparation and in Vivo Ocular Absorption Studies of Disulfiram Solid Dispersion

Screening of process variables to enhance the solubility of famotidine with 2-HydroxyPropyl-β-Cyclodextrin & PVP K-30 by using Plackett-Burman design approach

Development of PVP/PEG mixtures as appropriate carriers for the preparation of drug solid dispersions by melt mixing technique and optimization of dissolution using artificial neural networks

Dissolution rate enhancement of loratadine in polyvinylpyrrolidone K-30 solid dispersions by solvent methods

Amorphization within the tablet: Using microwave irradiation glass solution in situ

Formation of PVP/nimesulide microspheres by supercritical antisolvent coprecipitation

Coprecipitation of Cefuroxime Axetil-PVP composite microparticles by batch supercritical antisolvent process

Development and evaluation of rapidly dissolving buccal films of naftopidil: in vitro and in vivo evaluation

Aqueous solubility of diclofenac diethylamine in the presence of pharmaceutical additives: A comparative study with diclofenac sodium

Fast releasing oral electrospun PVP/CD nanofiber mats of taste-masked meloxicam

Insights into Polymers: Film Formers in Mouth Dissolving Films

Conteol of crystal growth in drug suspensions: 1) design of a conteol unit and application to acetaminophen suspensions)

Acrylic Emulsion Pressuresensitive Adhesives Using Polyvinyl Alcohol as a Protective Colloid

Preparation of microscopic catalysts and colloids for catalytic nitrate and nitrite reduction and their use in a hollow fibre dialyser loop reactor

Stability of dispersions of iron oxide in mixed solutions of polyvinylpyrrolidone and sodium alkyl sulfate

Freeze dried injectable drug product development: Selection of non functional additivies

Excipient selection in parenteral formulation development

The Effect of Polyvinylpyrrolidone (PVP) on Ocular Gel Forming Solutions Composed of Gellan and Calcium Gluconate

Formulation and Evaluation of Drug-free Ophthalmic Films Prepared by Using Various Synthetic Polymers

Nanocomplexes based polyvinylpyrrolidone K-17PF for ocular drug delivery of naringenin

Factorial designs in ophthalmic formulation development of Enalkiren

Nonirritant ophthalmology PVP-I composition, US20130177522A1

Preservative-free ocular hydrating agents in symptomatic contact lens wearers: Saline versus PVP solution

Evaluation of povidone-iodine as a disinfectant solution for contact lenses: Antimicrobial activity and cytotoxicity for corneal epithelial cells

Characterization and quantitation of PVP content in a silicone hydrogel contact lens produced by dual-phase polymerization processing

The Use of Polyvinylpyrrolidone as a Stabilizer in the Lyophilization of Brucella

Sugar-polymer hydrogen bond interactions in lyophilized amorphous mixtures

High fertilization and implantation rates after intracytoplasmic sperm injection

Application of Carbopol/PVP interpolymer complex to prepare mucoadhesive floating granule

Chitosan/pvp-based mucoadhesive membranes as a promising delivery system of betamethasone-17-valerate for aphthous stomatitis

Formulation, Characterization, and In Vitro Evaluation of Transdermal Patches for Inhibiting Crystallization of Mefenamic Acid

Mucosal applications of poloxamer 407-based hydrogels: An overview

PVA Cryogel as model hydrogel for iontophoretic transdermal drug delivery investigations. Comparison with PAA/PVA and PAA/PVP interpenetrating networks

Interpolymer complexation and its effect on bioadhesive strength 6 dissolution characteristics of buccal drug delivery systems

The relevance of patch testing in peristomal dermatitis

A clinical study on the tolerability of a liposomal povidone-iodine nasal spray: Implications for further development

Consideration of povidone-iodine as a public health intervention for COVID-19: Utilization as "Personal Protective Equipment" for frontline providers exposed in high-risk head and J o u r n a l P r e -p r o o f neck and skull base oncology care

Enhancing photostabilization of oxymetazoline, US20090281156A1

Formulation and evaluation of tramadol hydrochloride rectal suppositories

Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone

Formulation development and optimization of sustained release matrix tablet of Itopride HCl by response surface methodology and its evaluation of release kinetics

Delivery of poorly water soluble drug from swellable elementary osmotic pump and effect of formulation variables

Formulation and evaluation of controlled porosity osmotic pump for oral delivery of ketorolac

Formation and Characterization of Carbopol 971P-PVP Interpolymer complex and its application for sustained delivery of Acyclovir

Investigation and evaluation of an in situ interpolymer complex of carbopol with polyvinylpyrrolidone as a matrix for gastroretentive tablets of ranitidine hydrochloride

Enhancing the physical stability and supersaturation generation of amorphous drug-polyelectrolyte nanoparticle complex via incorporation of crystallization inhibitor at the nanoparticle formation step: A case of HPMC versus PVP

Au-PLA nanocomposites for photothermally controlled drug delivery

Magneto-electric Nanoparticles to Enable Field-controlled High-Specificity Drug Delivery to Eradicate Ovarian Cancer Cells

PVP and PEG doped CuO nanoparticles are more biologically active: Antibacterial, antioxidant, antidiabetic and cytotoxic perspective

Enhancement in in vitro anti-angiogenesis activity and cytotoxicity in lung cancer cell by pectin-PVP based curcumin particulates

Synthesis and characterization of pH-sensitive PAMPS/PVP nanogels in aqueous media

PVP superabsorbent nanogels

Radiation-induced synthesis of nanogels based on poly(N-vinyl-2-pyrrolidone)-A review

Electrospun biphasic drug release polyvinylpyrrolidone/ethyl cellulose core/sheath nanofibers

Electrospinning of poly(vinyl pyrrolidone): Effects of solvents on electrospinnability for the fabrication of poly( pphenylene vinylene) and TiO 2 nanofibers

Characterization and optimization of electrospun TiO 2 /PVP nanofibers using Taguchi design of experiment method

Quality by design approach for J o u r n a l P r e -p r o o f developing chitosan-Ca-alginate microspheres for colon delivery of celecoxibhydroxypropyl-β-cyclodextrin-PVP complex

Characterization and release behaviors of porous PCL/Eudragit RS microcapsules containing tulobuterol

Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP

Supercritical Assisted Atomization: Polyvinylpyrrolidone as Carrier for Drugs with Poor Solubility in Water

PVP/corticosteroid microspheres produced by supercritical antisolvent coprecipitation

Polymer-filled microcontainers for oral delivery loaded using supercritical impregnation

HPMC/PVP Dissolving Microneedles: a Promising Delivery Platform to Promote Trans-Epidermal Delivery of Alpha-Arbutin for Skin Lightening

Fabrication of composite microneedles integrated with insulin-loaded CaCO3 microparticles and PVP for transdermal delivery in diabetic rats

Rapidly-dissolvable microneedle patches via a highly scalable and reproducible soft lithography approach

Dissolving polymer influenza vaccination

Amphotericin B containing microneedle ocular patch for effective treatment of fungal keratitis

Influence of chitosan/clay in drug delivery of glucantime from PVP membranes

Synthesis of Cross Linked PVP Hydrogels and its Use for the Control Release of Anti-Asthmatic Drugs

Preparation and electrical sensitive behavior of poly (N-vinylpyrrolidone-co-acrylic acid) hydrogel with flexible chain nature

Novel Polyvinyl Pyrrolidone-Loaded Olopatadine HCl-Laden Doughnut Contact Lens to Treat Allergic Conjunctivitis

A kind of modified bovine serum albumin with great potential for applying in gene delivery

Biomaterials The immunotoxicity of graphene oxides and the effect of PVP-coating

Poly(vinylpyrrolidone) -A Versatile Polymer for Biomedical and Beyond Medical Applications

Effect of poly(vinyl pyrrolidone) on the morphology and physical properties of poly(vinyl alcohol)/sodium montmorillonite nanocomposite films

A Combined Study on the Distribution of Oxytetracycline and Polyvinylpyrrolidone in Rats -PubMed

Evaluation of polyvinylpyrrolidone as a cryoprotectant for adipose tissue-derived adult stem cells

Novel amphiphilic polyvinylpyrrolidone functionalized silicone particles as carrier for low-cost lipase immobilization

Does polyvinylpyrrolidone improve the chemical stability of cilazapril in solid state?

Study on mechanism for amorphous drug stabilization using Gelucire 50/13

Stabilisation of amorphous furosemide increases the oral drug bioavailability in rats

Effect of polyvinylpyrrolidone on complexation and dissolution rate of β-and hydroxypropyl-β-cyclodextrin complexes of celecoxib

Interpolymer Complexation and Blend Formation between Poly(N-vinyl-2-pyrrolidone) and Aliphatic Hydroxyl-Containing Polymers

Interaction of povidone with aromatic compounds II: Evaluation of ionic strength, buffer concentration, temperature, and pH by factorial analysis

Interaction of Povidone with Aromatic Compounds V: a Monophase

Hydrogen Bonding: Between Strengthening the Crystal Packing and Improving Solubility of Three Haloperidol Derivatives

Effects of PVP-iodine pH and calcium concentration on fluoride varnish anti-caries efficacy in vitro

Synthesis and Characterization of Thiolated PVP-Iodine Complexes: Key to Highly Mucoadhesive Antimicrobial Gels

In vitro antimicrobial activity of a new ophthalmic solution containing povidone-iodine 0.6% (IODIM®)

Wound Cleansing and Irrigation

Singular modification effects of metal cations and metal complex ions on the catalytic properties of metal colloidal nanocatalysts

Optimizing the antitumor selectivity of PVP-Hypericin re A549 cancer cells and HLF normal cells through pulsed blue light

An efficient protocol for isolation of inhibitor-free nucleic acids even from recalcitrant plants

Methods of preparation of biopolymer electrolytes: In Biopolymer electrolytes -Fundamentals and applications in energy storage

Physicochemical properties of direct with spray dried and ball milled solid dispersions of tadalafil in PVP-VA

Design of PVP/VA S-630 based tadalafil solid dispersion to enhance the dissolution rate

Modeling drug release from PVAc/PVP matrix tablets

Functional assessment of four types of disintegrants and their effect on the spironolactone release properties

Preparation and assessment of novel coprocessed superdisintegrant consisting of crospovidone and sodium starch glycolate: A technical note

PVP (Polyvinylpyrrolidone)

Subject: Re-review of Polyvinylpyrrolidone (PVP)

CFR -Code of Federal Regulations Title 21

Anaphylaxis to polyvinylpyrrolidone in povidone-iodine for impetigo contagiosum in a boy with atopic dermatitis

Anaphylaxis to polyvinylpyrrolidone after vaginal application of povidone-iodine

An unusual complication of late onset allergic contact dermatitis to povidone iodine in oral & maxillofacial surgery -a report of 2 cases

Embolized crospovidone (poly[N-vinyl-2-pyrrolidone]) in the lungs of intravenous drug users

Effect of adjuvants on tackiness of polyvinylpyrrolidone film coating

Possible prophylactic or preventive role of topical povidone iodine during accidental ocular exposure to 2019-nCoV, Graefe's Arch

In Vitro Bactericidal and Virucidal Efficacy of Povidone-Iodine Gargle/Mouthwash Against Respiratory and Oral Tract Pathogens

Consideration of povidone-iodine as a public health intervention for COVID-19: Utilization as "Personal Protective Equipment" for frontline providers exposed in high-risk head and neck and skull base oncology care

Rapid and Effective Virucidal Activity of Povidone-Iodine Products Against Middle East Respiratory Syndrome Coronavirus

CoV) and Modified Vaccinia Virus Ankara (MVA)

A Surgical Protocol to Mitigate the SARS-CoV-2 Transmission Using Multifocal Povidone-Iodine Applications in Lacrimal Surgeries During Coronavirus Disease 2019 (COVID-19) Pandemic

Topical preparations to reduce <scp>SARS-CoV</scp> -2 aerosolization in head and neck mucosal surgery

Rapid In-Vitro Inactivation of Severe Acute Respiratory Syndrome Coronavirus

Using Povidone-Iodine Oral Antiseptic Rinse

In-VivoToxicity Studies and In-Vitro Inactivation of SARS-CoV-2 by Povidone-iodine In-situ Gel Forming Formulations

SARS-CoV-2 Viral Inactivation Using Low Dose Povidone-Iodine Oral Rinse-Immediate Application for the Prosthodontic Practice

Povidone-Iodine Demonstrates Rapid In Vitro Virucidal Activity Against SARS-CoV-2, The Virus Causing COVID-19 Disease

Comparison of In Vitro Inactivation of SARS CoV-2 with Hydrogen Peroxide and Povidone-Iodine Oral Antiseptic Rinses

The influence of long-term treatment with povidone-iodine on thyroid function

COVID-19: implications for immunosuppression in kidney disease and transplantation

Cardiovascular collapse following povidone-iodine wash

A comparison of the irritant and allergenic properties of antiseptics